The UroNav MR/Ultrasound Fusion Biopsy System represents a significant advancement in prostate cancer diagnosis. This innovative technology seamlessly integrates real-time ultrasound imaging with pre-operative multiparametric MRI data, creating a precise 3D image of the prostate. This fusion of imaging modalities allows for targeted biopsies, enabling urologists to pinpoint suspicious areas identified on the MRI with greater accuracy than traditional methods. By improving the precision of biopsies, UroNav helps to increase the detection of clinically significant prostate cancers while minimizing the sampling of non-cancerous or low-risk areas. This can lead to more informed treatment decisions and potentially reduce the need for repeat biopsies.
